Have you been considering InterStim therapy to treat your overactive bladder but you are worried about complications from the device or the surgery? In a new study looking at 272 patients who received InterStim therapy for overactive bladder, the rate of adverse effects (AE) was much lower than in past studies.

The study found that 30 percent of patients had some level of adverse effects, but just one had a complication considered serious. The most common side effects were an undesirable change in stimulation and device site pain, most of which occurred in the first three months after surgery.